Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.291 +0.171 (+8.07%)
Streaming Delayed Price Updated: 3:44 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
37 38 Next >
Cassava Stock Could Jump More Than 200 Times
Cassava's Alzheimer's drug appears backed by strong data and plenty of public support. That's a winning combination for SAVA stock. 
Via InvestorPlace
Cassava Sciences’ Stock Remains an Enigma
Cassava Sciences has lost 26% for the month through Oct. 27. Entering October, SAVA stock looked to go on a big run. It did the opposite. 
Via InvestorPlace
Buy SAVA Stock on Dips as its Phase 3 Trial Moves Along
SAVA stock likely won't make another big move until Phase 3 trial data for Simulfilam comes in, so ease into it until then 
Via InvestorPlace
SHAREHOLDER ALERT: Robbins LLP Investigates Cassava Sciences, Inc. (SAVA) on Behalf of Shareholders
From Robbins LLP
Via Business Wire
SAVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Cassava Sciences, Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA)
From The Law Offices of Frank R. Cruz
Via Business Wire
CLASS ACTION UPDATE for KPLT, SAVA and HNST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / October 26, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Initial Public Offering Lawsuit
CASSAVA DEADLINE ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
CASSAVA SCIENCES DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Cassava Sciences and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
LAWSUITS FILED AGAINST KPLT, SAVA and ZEV - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / October 25, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
Last Day to Actively Participate in Cassava Sciences, Inc. (SAVA) Class Action: Bronstein, Gewirtz & Grossman, LLC
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, SAVA and INNV
NEW YORK, NY / ACCESSWIRE / October 25, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Topics Lawsuit
CASSAVA DEADLINE ALERT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
SAVA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
CASSAVA UPDATE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
CASSAVA SCIENCES 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA
From Kahn Swick & Foti, LLC
Via Business Wire
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAVA, EAR and HYZN
NEW YORK, NY / ACCESSWIRE / October 22, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies.... 
From The Gross Law Firm
Via AccessWire
Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA)
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
DEADLINE TUESDAY NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SAVA, EAR and ZEV
NEW YORK, NY / ACCESSWIRE / October 22, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
Athira CEO Resigns After Data Manipulation Firestorm, But Alzheimer's Stock Pops
Athira CEO Leen Kawas resigned after an investigation found she altered images. 
Via Investor's Business Daily
LAWSUITS FILED AGAINST SAVA, HYRE and SPPI - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / October 22, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Lawsuit
CLASS ACTION UPDATE for SAVA, SPPI and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / October 22, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
Jim Cramer Prefers Square To Marqeta, Recommends Trimming Positions In This Stock
On CNBC’s "Mad... 
Via Benzinga
CASSAVA CLASS ACTION REMINDER
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
DEADLINE TUESDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, SAVA and NNOX
NEW YORK, NY / ACCESSWIRE / October 21, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market
Cortexyme is testing a twice-day pill to treat Alzheimer's disease. 
Via Investor's Business Daily
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.